Mosanna Therapeutics Appoints David Weber As Chief Executive Officer
06/09/25, 2:01 PM
Location
redwood cityIndustry
biotechnology
Position
chief executive officer
Mosanna Therapeutics has announced the appointment of David Weber, Ph.D., as Chief Executive Officer. This leadership change comes as the company closes $80 million in Series A funding to advance its innovative sleep apnea treatment, MOS118.
Company Info
Location
redwood city, california, united states
Additional Info
Mosanna Therapeutics is a clinical-stage biotech company pioneering a novel pharmaceutical approach to treating obstructive sleep apnea (OSA) with an easily administered nasal spray. Designed to help restore the body's natural airway control during sleep, Mosanna's lead therapy, MOS118, offers a drug-based alternative to traditional mechanical treatments and is currently being evaluated in a Phase 1 clinical trial. Founded in 2022, the company has raised more than $80 million from investors including Pivotal bioVenture Partners, EQT Life Sciences, Forbion, Norwest, Broadview Ventures, Forty51 Ventures, Supermoon Capital and High-Tech Gründerfonds (HTGF). Mosanna has offices in Redwood City, California and Basel, Switzerland.
Related People
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Ph
Ph • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more
Unlock Verified Contacts + AI Outreach
Instantly access verified contact emails — and let Fundz AI draft a hyper-personalized message based on their role, company, and your company's offering.
Dh
Dh • Executive
Email hidden • Upgrade to unlock
Trusted by teams at Google, Oracle, HubSpot & more